Position in CLYM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$147,364,243
+$69,952,812 QoQ
Shares Held
11,300,939
0.0% QoQ
Ownership
19.7%
of shares outstanding
% of Portfolio
1.30%
of 13F equity value
Holder Rank
#1
of 108 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CLYM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RA CAPITAL MANAGEMENT, L.P. holds $11,082,969,028 across 75 Biotechnology names. CLYM ranks #22 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
10,281,496 | $2,742,280,613 | |
| 2 | PBLS |
Parabilis Medicines, Inc.
|
28,933,371 | $791,906,364 | |
| 3 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
6,666,837 | $740,218,912 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
11,474,599 | $667,018,439 | |
| 5 | SION |
Sionna Therapeutics, Inc.
|
9,905,045 | $435,722,929 | |
| 6 | TYRA |
Tyra Biosciences, Inc.
|
12,198,625 | $389,624,082 | |
| 7 | EWTX |
Edgewise Therapeutics, Inc.
|
8,392,730 | $340,996,619 | |
| 8 | NAMS |
NewAmsterdam Pharma Co N.V.
|
9,883,524 | $330,779,298 |
All Filings in CLYM
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-07-02 | $299,914,499 | 23,249,186 | Shares | Sole | 2026-07-07 | |
| 2026-06-30 | $147,364,243 | 11,300,939 | Shares | Sole | 2026-08-14 | |
| 2026-04-27 | $214,998,309 | 22,631,401 | Shares | Sole | 2026-04-29 | |
| 2026-03-31 | $77,411,431 | 11,300,939 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $45,175,312 | 11,293,828 | Shares | Sole | 2026-02-17 | |
| 2025-12-11 | $41,292,553 | 17,953,284 | Shares | Sole | 2025-12-15 | |
| 2025-09-30 | $63,152,725 | 31,419,267 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $38,959,890 | 31,419,267 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $38,331,504 | 31,419,267 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $56,554,680 | 31,419,267 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $159,924,068 | 31,419,267 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $223,390,987 | 31,419,267 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $36,033,326 | 13,150,849 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $35,507,292 | 13,150,849 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $34,586,732 | 13,150,849 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $36,822,377 | 13,150,849 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $38,137,462 | 13,150,849 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $48,263,615 | 13,150,849 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $42,477,242 | 13,150,849 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $39,715,563 | 13,150,849 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $110,335,623 | 13,150,849 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $137,557,880 | 13,150,849 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $236,452,265 | 13,150,849 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||